Display options
Share it on

Mol Neuropsychiatry. 2016 Oct;2(3):124-132. doi: 10.1159/000447970. Epub 2016 Jul 21.

Dopamine D2L Receptor Is Required for Visual Discrimination and Reversal Learning.

Molecular neuropsychiatry

Makiko Morita, Yanyan Wang, Toshikuni Sasaoka, Kinya Okada, Minae Niwa, Akira Sawa, Takatoshi Hikida

Affiliations

  1. Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  2. Department of Pharmacology and Beckman Institute, University of Illinois, Urbana-Champaign, Ill., USA.
  3. Brain Research Institute, Niigata University, Niigata, Japan.
  4. Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Md., USA.

PMID: 27867937 PMCID: PMC5109995 DOI: 10.1159/000447970

Abstract

The corticostriatothalamic circuit regulates learning behaviors via dopamine neurotransmission. D2 long (D2L) receptors are an isoform of dopamine D2 receptors (D2Rs) and may act mainly at postsynaptic sites. It is well known that D2Rs influence high brain functions, but the roles of individual D2R isoforms are still unclear. To assess the influence of D2L receptors in visual discrimination learning, we performed visual discrimination and reversal tasks with D2L knockout mice using a touchscreen operant system. There were no significant differences in an operant conditioning task between genotypes. However, D2L knockout mice were impaired in both visual discrimination and reversal learning tasks. D2L knockout mice were also significantly slower than wild-type mice in collecting the reward in the visual discrimination task. These results indicate that D2L receptors play an important role in visual discrimination and reversal learning.

Keywords: Dopamine receptor; Flexibility; Touchscreen

References

  1. Neurosci Lett. 2004 Aug 12;366(2):172-5 - PubMed
  2. Curr Opin Neurobiol. 2010 Apr;20(2):199-204 - PubMed
  3. J Neurosci. 2011 Jun 8;31(23):8625-33 - PubMed
  4. Neuron. 2010 Jun 24;66(6):896-907 - PubMed
  5. Front Behav Neurosci. 2009 Feb 23;3:2 - PubMed
  6. Neuroreport. 2001 Apr 17;12(5):1035-8 - PubMed
  7. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2802-6 - PubMed
  8. Nat Protoc. 2013 Oct;8(10):1961-84 - PubMed
  9. Brain Cogn. 1989 Sep;11(1):114-26 - PubMed
  10. Front Neurosci. 2013 Nov 05;7:201 - PubMed
  11. Annu Rev Neurosci. 2005;28:109-26 - PubMed
  12. Neuropharmacology. 2012 Mar;62(3):1191-203 - PubMed
  13. Biol Psychiatry. 2009 Sep 15;66(6):586-93 - PubMed
  14. Annu Rev Neurosci. 2011;34:441-66 - PubMed
  15. Neuroscience. 2014 Dec 12;282:49-59 - PubMed
  16. Neuroscience. 2013 Sep 17;248:479-87 - PubMed
  17. Annu Rev Neurosci. 1993;16:299-321 - PubMed
  18. Learn Mem. 2015 Nov 16;22(12):622-32 - PubMed
  19. Nat Neurosci. 2011 Jul 10;14(8):1033-8 - PubMed
  20. Neuroscience. 2014 Dec 12;282:248-57 - PubMed
  21. Neuropsychopharmacology. 2006 Feb;31(2):297-309 - PubMed
  22. Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):342-7 - PubMed
  23. Neurobiol Aging. 2013 Mar;34(3):731-44 - PubMed
  24. Neuropsychopharmacology. 2016 Mar;41(4):971-8 - PubMed
  25. Neuropsychopharmacology. 2009 May;34(6):1578-89 - PubMed
  26. J Neurosci. 2002 Apr 1;22(7):2977-88 - PubMed
  27. Neuron. 2001 Sep 13;31(5):681-97 - PubMed
  28. Neurosci Lett. 1991 Jan 14;122(1):37-40 - PubMed
  29. Sci Rep. 2015 Oct 01;5:14613 - PubMed
  30. Nature. 1995 Oct 5;377(6548):424-8 - PubMed
  31. Neuroscience. 2002;113(4):755-65 - PubMed
  32. Schizophr Res. 2007 Jul;93(1-3):296-303 - PubMed
  33. J Neurosci. 1995 May;15(5 Pt 1):3429-39 - PubMed
  34. Nature. 2000 Nov 9;408(6809):199-203 - PubMed
  35. Front Psychol. 2014 Nov 12;5:1301 - PubMed
  36. Pharmacol Rev. 2015 Jul;67(3):681-96 - PubMed
  37. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12764-9 - PubMed
  38. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7731-6 - PubMed
  39. Hippocampus. 2007;17(9):898-908 - PubMed
  40. J Neurosci. 2012 Sep 26;32(39):13421-32 - PubMed
  41. J Affect Disord. 2008 Feb;106(1-2):1-27 - PubMed
  42. J Neurosci. 2000 Nov 15;20(22):8305-14 - PubMed
  43. Alcohol. 2011 Nov;45(7):631-9 - PubMed
  44. Neuropharmacology. 2012 Mar;62(3):1263-72 - PubMed
  45. Science. 2008 Aug 8;321(5890):848-51 - PubMed
  46. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4305-9 - PubMed
  47. Prog Neurobiol. 2002 May;67(1):53-83 - PubMed
  48. Behav Brain Res. 2008 Dec 22;195(2):246-50 - PubMed
  49. Neurobiol Aging. 2005 Apr;26(4):521-30 - PubMed
  50. Mol Psychiatry. 2014 Dec;19(12):1258-66 - PubMed
  51. BMC Neurosci. 2012 Feb 15;13:18 - PubMed
  52. Behav Brain Res. 2000 Apr;109(1):99-111 - PubMed
  53. J Neurosci Methods. 2010 May 15;188(2):219-25 - PubMed

Publication Types

Grant support